INSIGHTS ON DRUG DEVELOPMENT

  • Maintain Control Of Pharmaceutical Water Systems
    4/10/2026

    Early TOC excursions often reveal hidden risks in water systems. Capturing samples at the moment of deviation helps teams confirm root causes faster, reduce uncertainty, and maintain control.

  • Streamlining Cell Line Development For Antibodies
    8/27/2025

    Streamline your antibody production with a robust Cell Line Development strategy. Discover how automation, analytics, and digital tools accelerate development from clone selection to commercialization.

  • Patient-Centric Formulations In Pediatric Adherence
    11/13/2025

    Improving pediatric adherence requires age-appropriate formulations, taste-masking, and swallowability strategies. Regulatory, clinical, and technological insights help overcome barriers and support safer, more effective therapies for children across developmental stages.

  • Simplify Cell Line Development
    11/7/2025

    A streamlined workflow combining microfluidic dispensing and multimodal imaging enables efficient single-cell isolation, viability assessment, and outgrowth analysis to support cell line development.

  • 3D Cell Culture Reveals Undetectable Drug Efficacy In Traditional Systems
    3/10/2025

    Drug discovery now targets cancer stem cells (CSCs) to achieve long-term tumor eradication, which moves beyond traditional chemotherapeutics. Discover an advanced screening platform that better predicts CSC inhibitor efficacy.

DRUG DEVELOPMENT SOLUTIONS

  • Routine cell culture? Check!

    For researchers who need consistent experimental outcomes, Mateo TL enables all lab members to check and document cell growth status conveniently and comfortably.

    Measure confluency consistently, thereby increasing the confidence in the success of their downstream experiments.

  • SoftMax® Pro Software - The most published microplate reader control and data analysis software

    Preconfigured protocols and custom assay workflows simplify microplate data acquisition and analysis

    SoftMax® Pro Software for Windows 10 is designed to provide the simplicity, flexibility and power required for advanced data analysis. It provides ready-to-run protocols, analysis algorithms, and 21 different curve fit options. Every step is optimized for data acquired from a Molecular Devices microplate reader or data imported from another source to simplify analysis and reporting. Compliance tools are available for regulated laboratories providing end-to-end chain of custody.

  • Enhance tablet effectiveness across various dosages with an excipient that offers excellent compressibility and stability for APIs, which eliminates the need for intense processing and provides rapid disintegration.

  • From cancer models to high-throughput screening, Organ-Chip platforms accelerate development, improve safety, and support regulatory compliance for next-generation therapies.

  • Explore a suite of services designed to accelerate drug discovery and development, from custom reagent production and high-throughput screening to advanced in vitro pharmacology and DMPK assays.